These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

105 related articles for article (PubMed ID: 6876537)

  • 1. [Various practical observations on the use of heparin in recent myocardial infarction].
    Mamont B
    Kardiol Pol; 1983; 26(1):85-8. PubMed ID: 6876537
    [No Abstract]   [Full Text] [Related]  

  • 2. [Heparin].
    Aiach M; Fiessinger JN; Chousterman M
    Rev Prat; 1977 Dec; 27(57):3953-74. PubMed ID: 345399
    [No Abstract]   [Full Text] [Related]  

  • 3. [Thrombosis and heart infarct prevention using subcutaneous heparin therapy].
    Steger W
    Fortschr Med; 1974 Jan; 92(2):76-9. PubMed ID: 4818252
    [No Abstract]   [Full Text] [Related]  

  • 4. [Anticoagulant therapy in myocardial infarct. Considerations based on data from the literature and personal results obtained by the administration of subcutaneous heparin-calcium].
    Bernardi P; Cavazza M; Bastagli L; Fontana F; Ventura C; Spagnolo N; Guardigli G
    Clin Ter; 1986 Oct; 119(2):91-109. PubMed ID: 3791904
    [No Abstract]   [Full Text] [Related]  

  • 5. [Postoperative thrombosis. Prevention with small doses of subcutaneous heparin].
    Thibault P
    Nouv Presse Med; 1972 Dec; 1(43):2915-6. PubMed ID: 4648954
    [No Abstract]   [Full Text] [Related]  

  • 6. Low-dose heparin after myocardial infarction.
    Handley AJ
    Lancet; 1972 Sep; 2(7778):623-4. PubMed ID: 4116776
    [No Abstract]   [Full Text] [Related]  

  • 7. [Value and practical management of anticoagulant therapy by subcutaneous injection of concentrated calcium heparinate].
    Di Matteo J; Picard R; Cornu P; Vacheron A; Bousquet O
    Arch Mal Coeur Vaiss; 1968 May; 61(5):724-34. PubMed ID: 4971372
    [No Abstract]   [Full Text] [Related]  

  • 8. [Evaluation of the nature and dynamics of hemostatic changes in myocardial infarction. III. Effect of the method of heparin administration on selected parameters of the system of hemostasis].
    Zapolska-Downar D; Borodin M; Gregorczyk J; Chełstowski K; Sprogis W
    Przegl Lek; 1988; 45(6):508-12. PubMed ID: 3252353
    [No Abstract]   [Full Text] [Related]  

  • 9. [Subcutaneous heparin therapy].
    Raynaud R; Brochier M; Chatelain B
    Sem Hop; 1967 May; 43(24):1628-9. PubMed ID: 4292746
    [No Abstract]   [Full Text] [Related]  

  • 10. First case report of spontaneous pulmonary hemorrhage following heparin therapy in acute myocardial infarction.
    Kok LC; Sugihara J; Druger G
    Hawaii Med J; 1996 May; 55(5):83-4. PubMed ID: 8690568
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The subcutaneous use of heparin in the prevention of venous thrombosis after myocardial infarction.
    Pitney WR; Pussell BA; Harris M; Manohar D
    Med J Aust; 1974 Jan; 1(2):38-40. PubMed ID: 4816047
    [No Abstract]   [Full Text] [Related]  

  • 12. [Controlled heparinization during hemosorption].
    Marochkov AV; Iurchenko AA; Kravtsov NN
    Vestn Khir Im I I Grek; 1985 Mar; 134(3):101-3. PubMed ID: 4002508
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Heparin in acute myocardial infarct?].
    Klingemann HG; Egbring R
    Dtsch Med Wochenschr; 1981 Apr; 106(17):544-6. PubMed ID: 7215183
    [No Abstract]   [Full Text] [Related]  

  • 14. Angiographic and clinical outcomes in patients receiving low-molecular-weight heparin versus unfractionated heparin in ST-elevation myocardial infarction treated with fibrinolytics in the CLARITY-TIMI 28 Trial.
    Sabatine MS; Morrow DA; Montalescot G; Dellborg M; Leiva-Pons JL; Keltai M; Murphy SA; McCabe CH; Gibson CM; Cannon CP; Antman EM; Braunwald E;
    Circulation; 2005 Dec; 112(25):3846-54. PubMed ID: 16291601
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Heparin induced thrombocytopenia: case reports and a prospective study.
    Romeril KR; Hickton CM; Hamer JW; Heaton DC
    N Z Med J; 1982 Apr; 95(706):267-9. PubMed ID: 6953369
    [No Abstract]   [Full Text] [Related]  

  • 16. [Comparison of various methods of heparin treatment].
    Chojnowski K; Judkiewicz L; Ciszewski R; Majda J
    Pol Tyg Lek; 1985 Nov; 40(44):1232-4. PubMed ID: 3911186
    [No Abstract]   [Full Text] [Related]  

  • 17. [A heparin bolus in acute myocardial infarct?].
    Görge G; Erbel R
    Dtsch Med Wochenschr; 1994 Mar; 119(12):438-9. PubMed ID: 8143560
    [No Abstract]   [Full Text] [Related]  

  • 18. A METHOD OF INTRAVENOUS ADMINISTRATION OF HEPARIN IN MYOCARDIAL INFARCTION.
    HARDEN RM
    Br Med J; 1963 Nov; 2(5365):1106-7. PubMed ID: 14057714
    [No Abstract]   [Full Text] [Related]  

  • 19. Conjunctive administration of intravenous heparin attenuates cross-linked fibrin degradation in patients treated with streptokinase.
    Galvani M; Abendschein DR; Ferrini D; Ottani F; Rusticali F; Eisenberg PR
    Thromb Haemost; 1996 Sep; 76(3):339-43. PubMed ID: 8883267
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Small doses of heparin in the prevention of deep venous thrombosis.
    Ham JM; Lawrence J
    Lancet; 1971 Aug; 2(7721):428. PubMed ID: 4105194
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.